Results about: bioinformatics
A bioinformatics analysis of pairing 64 drugs used to treat breast cancer allows researchers at IRB Barcelona to identify 10 previously untested combinations with potential to tackle resistance to breast cancer treatment.
In spite of the many drugs available to treat breast cancer, resistance continues to be a problem.
Structural biologists endorse the potential of their field to extract quality information from “big data”
International experts in structural biology, such as Nobel laureate Ada E. Yonath, and in massive genomic analysis, such as the bioinformatician Chris Sander—one of the fathers of biocomputation—, are gathering in Barcelona this week with the aim to identify synergies and throw light on the jumble of massive biological data currently available.
The Barcelona Biomed Conference organised by IRB Barcelona and the BBVA Foundation will be held from today 28 to 30 November at the Institut d’Estudis Catalans.
This afternoon, there will be an open debate on “Women in science”, chaired by Ada E. Yonath.
Scientists at the Institute for Research in Biomedicine (IRB Barcelona) and the KTH Royal Institute of Technology in Stockholm develop a new method that predicts the way in which proteins move to exert their biological functions.
They have demonstrated that protein movement is governed by the general shape of these molecules, thereby providing new data on how proteins work—a key step for drug development.
Stephan-Otto: “In the near future, there’s going to be one biostatistician in every biomedical laboratory”
Camille Stephan-Otto Attolini, who holds a PhD in Biomathematics, heads the Biostatistics and Bioinformatics Core Facility at IRB Barcelona.
The “Meet Our Scientists” video “Deciphering the bytes of life” explains her work and shows us the personal side of this scientist.